Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ze Fang

Showing results (131-140 of 227) with videos related to

Pageof 23
Sort By:
Chirality|April 24, 2015
Chirality Influence of Zaltoprofen Towards UDP-Glucuronosyltransferases (UGTs) Inhibition PotentialLin Jia, Cuimin Hu, Haina Wang, et al.
Chemosphere|May 4, 2018
New insights for risks of chlorophenols (CPs) exposure: Inhibition of UDP-glucuronosyltransferases (UGTs)Kai Yang, Zhi-Wei Fu, Yun-Feng Cao, et al.
Cancer Research and Treatment|November 16, 2018
Patient and Care Delays of Breast Cancer in ChinaYue-Lin Li, Ya-Chao Qin, Lu-Ying Tang, et al.
Die Pharmazie|May 11, 2011
Inhibitory potential of chlormadinone acetate (CMA) on five important UDP-glucuronosyltransferases in human liverTing Huang, Zhong-Ze Fang, Yan-Yan Zhang, et al.
Toxicology and Applied Pharmacology|April 20, 2016
Comparison of the inhibitory effects of tolcapone and entacapone against human UDP-glucuronosyltransferasesXia Lv, Xin-Xin Wang, Jie Hou, et al.
Fitoterapia|December 15, 2012
Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidationHang Lu, Zhong-Ze Fang, Yun-Feng Cao, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|December 23, 2014
The Inhibition of the Components from Shengmai Injection towards UDP-GlucuronosyltransferaseLi-Peng Jiang, Jin Zhao, Yun-Feng Cao, et al.
American Journal of Translational Research|August 12, 2022
Promoting the formation of Pi-stacking interaction to improve CTL cells activation between modified peptide and HLAYing Zhu, Chang-Xin Huang, Le Zhang, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 19, 2014
PPARα-dependent exacerbation of experimental colitis by the hypolipidemic drug fenofibrateYunpeng Qi, Changtao Jiang, Naoki Tanaka, et al.
Phytotherapy Research : PTR|October 30, 2010
Reversible inhibition of three important human liver cytochrome p450 enzymes by tilirosideDong-Xue Sun, Jin-Cai Lu, Zhong-Ze Fang, et al.
Pageof 23

Showing results (131-140 of 227) with videos related to

Sort By:
Pageof 23
Chirality|April 24, 2015
Chirality Influence of Zaltoprofen Towards UDP-Glucuronosyltransferases (UGTs) Inhibition PotentialLin Jia, Cuimin Hu, Haina Wang, et al.
Chemosphere|May 4, 2018
New insights for risks of chlorophenols (CPs) exposure: Inhibition of UDP-glucuronosyltransferases (UGTs)Kai Yang, Zhi-Wei Fu, Yun-Feng Cao, et al.
Cancer Research and Treatment|November 16, 2018
Patient and Care Delays of Breast Cancer in ChinaYue-Lin Li, Ya-Chao Qin, Lu-Ying Tang, et al.
Die Pharmazie|May 11, 2011
Inhibitory potential of chlormadinone acetate (CMA) on five important UDP-glucuronosyltransferases in human liverTing Huang, Zhong-Ze Fang, Yan-Yan Zhang, et al.
Toxicology and Applied Pharmacology|April 20, 2016
Comparison of the inhibitory effects of tolcapone and entacapone against human UDP-glucuronosyltransferasesXia Lv, Xin-Xin Wang, Jie Hou, et al.
Fitoterapia|December 15, 2012
Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidationHang Lu, Zhong-Ze Fang, Yun-Feng Cao, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|December 23, 2014
The Inhibition of the Components from Shengmai Injection towards UDP-GlucuronosyltransferaseLi-Peng Jiang, Jin Zhao, Yun-Feng Cao, et al.
American Journal of Translational Research|August 12, 2022
Promoting the formation of Pi-stacking interaction to improve CTL cells activation between modified peptide and HLAYing Zhu, Chang-Xin Huang, Le Zhang, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 19, 2014
PPARα-dependent exacerbation of experimental colitis by the hypolipidemic drug fenofibrateYunpeng Qi, Changtao Jiang, Naoki Tanaka, et al.
Phytotherapy Research : PTR|October 30, 2010
Reversible inhibition of three important human liver cytochrome p450 enzymes by tilirosideDong-Xue Sun, Jin-Cai Lu, Zhong-Ze Fang, et al.
Pageof 23